In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to the novel oxazolidinones eperezolid (PNU-100592) and linezolid (PNU-100766)

被引：10

作者：

Hoppe, JE ^{[1
]}

机构：

[1] Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany

来源：

JOURNAL OF CHEMOTHERAPY | 1999年 / 11卷 / 03期

关键词：

D O I：

10.1179/joc.1999.11.3.220

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：220 / 221

页数：2

共 7 条

[1] COMPARISON OF MEDIA FOR AGAR DILUTION SUSCEPTIBILITY TESTING OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS [J].

HOPPE, JE ;

TSCHIRNER, T .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (09) :775-779

[2] In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azitbromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine) [J].

Hoppe, JE ;

Bryskier, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :965-966

[3] State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis [J].

Hoppe, JE .

INFECTION, 1998, 26 (04) :242-246

[4] In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones [J].

Jones, RN ;

Johnson, DM ;

Erwin, ME .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :720-726

[5]

National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS

[6]

STRATTON CW, 1997, ANTIMICROB INFECT DI, V16, P69

[7] In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents [J].

Zurenko, GE ;

Yagi, BH ;

Schaadt, RD ;

Allison, JW ;

Kilburn, JO ;

Glickman, SE ;

Hutchinson, DK ;

Barbachyn, MR ;

Brickner, SJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :839-845

← 1 →